Mesa Laboratories Inc
NASDAQ:MLAB
Mesa Laboratories Inc
Gross Profit
Mesa Laboratories Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mesa Laboratories Inc
NASDAQ:MLAB
|
Gross Profit
$129.9m
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Gross Profit
$8.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Gross Profit
$10.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Gross Profit
$13.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Gross Profit
$22.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Gross Profit
$4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
See Also
What is Mesa Laboratories Inc's Gross Profit?
Gross Profit
129.9m
USD
Based on the financial report for Dec 31, 2023, Mesa Laboratories Inc's Gross Profit amounts to 129.9m USD.
What is Mesa Laboratories Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
16%
Over the last year, the Gross Profit growth was -4%. The average annual Gross Profit growth rates for Mesa Laboratories Inc have been 17% over the past three years , 16% over the past five years , and 16% over the past ten years .